Literature DB >> 12631947

Management of Lassa fever in European countries.

Natasha S Crowcroft1.   

Abstract

The UK Public Health Laboratory Service hosted a meeting in London during November 2000 to discuss the management of Lassa fever following the four cases which had occurred in 1999/2000. Participants were invited because they had recent clinical or laboratory experience of managing cases of Lassa fever or had been involved in public health aspects of a case of this infection. The meeting was closed to enable free and frank discussion of confidential matters. This is a report of the general issues and recommendations which arose from the discussion.

Entities:  

Mesh:

Year:  2002        PMID: 12631947     DOI: 10.2807/esm.07.03.00337-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  7 in total

1.  Early-onset sensorineural hearing loss in Lassa fever.

Authors:  T S Ibekwe; P O Okokhere; D Asogun; F F Blackie; M M Nwegbu; K W Wahab; S A Omilabu; G O Akpede
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-01       Impact factor: 2.503

Review 2.  Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.

Authors:  Daniel G Bausch; Christiane M Hadi; Sheik Humarr Khan; Juan J L Lertora
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

Review 3.  Viral hemorrhagic fevers: current status of endemic disease and strategies for control.

Authors:  Dennis J Cleri; Anthony J Ricketti; Richard B Porwancher; Luz S Ramos-Bonner; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2006-06       Impact factor: 5.982

4.  Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.

Authors:  Clara Lehmann; Matthias Kochanek; Diana Abdulla; Stephan Becker; Boris Böll; Anne Bunte; Daniel Cadar; Arno Dormann; Markus Eickmann; Petra Emmerich; Torsten Feldt; Christina Frank; Jochen Fries; Martin Gabriel; Udo Goetsch; René Gottschalk; Stephan Günther; Michael Hallek; Dieter Häussinger; Christian Herzog; Björn Jensen; Felix Kolibay; Michael Krakau; Georg Langebartels; Toni Rieger; Lars Schaade; Jonas Schmidt-Chanasit; Edgar Schömig; Gundolf Schüttfort; Alexander Shimabukuro-Vornhagen; Michael von Bergwelt-Baildon; Ulrike Wieland; Gerhard Wiesmüller; Timo Wolf; Gerd Fätkenheuer
Journal:  Euro Surveill       Date:  2017-09

5.  Lessons learnt from imported cases and onward transmission of Lassa fever in Europe support broader management of viral haemorrhagic fevers.

Authors:  Roger Hewson
Journal:  Euro Surveill       Date:  2017-09

6.  Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods.

Authors:  Anna Grahn; Andreas Bråve; Thomas Tolfvenstam; Marie Studahl
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

7.  A strategic vaccine facility for the UK.

Authors:  Jacqueline M Duggan; Timothy J G Brooks
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.